Campycins are novel broad spectrum antibacterials killingCampylobacter jejuniby targeting the essential major outer membrane protein (MOMP)

Author:

Zampara Athina,Gencay Yilmaz Emre,Brøndsted LoneORCID,Sørensen Martine Camilla HolstORCID

Abstract

ABSTRACTPyocins are high molecular weight bacteriocins produced byPseudomonas aeruginosathat can be retargeted to new bacterial species by exchanging the pyocin tail fibers with bacteriophage receptor binding proteins (RBPs). Here, we develop retargeted pyocins called campycins as new antibacterials to specifically and effectively kill the major foodborne pathogenCampylobacter jejuni.We used two diverse RBPs (H-fibers) encoded by CJIE1 prophages found in the genomes ofC. jejunistrains CAMSA2147 and RM1221 to construct Campycin 1 and Campycin 2, respectively. Together Campycin 1 and 2 could target allC. jejunistrains tested due to complementary antibacterial spectrums. In addition, both campycins led to more than 3 log reductions inC. jejunicounts under microaerobic conditions at 42°C, whereas the killing efficiency was less efficient under anaerobic conditions at 5°C. We furthermore discovered that both H-fibers used to construct the campycins bind to the essential major outer membrane protein (MOMP) present in allC. jejuni,in a strain specific manner. Protein sequence alignment and structural modelling suggest that the highly variable extracellular loops of MOMP form the binding sites of the diverse H-fibers. Furtherin silicoanalyses of 5000 MOMP sequences suggest that the protein fall into three major clades predicted to be targeted by either Campycin 1 or Campycin 2. Thus, campycins are promising antibacterials againstC. jejuniexpected to broadly target numerous strains of this human pathogen found in nature and agriculture.IMPORTANCECampylobacter jejuniis the leading cause of bacterial foodborne gastroenteritis and responsible for more than 800 million cases globally each year posing a continuous risk to human health and a huge economic and societal burden. Here, we developed re-targeted R2 pyocins (campycins) as novel antibacterials againstC. jejuniby using the receptor binding proteins of CJIE1 prophages observed in manyC. jejunigenomes. Notably, campycins broadly target the highly variable yet essential major outer membrane protein (MOMP), and result in more than 3-log reductions inC. jejunicounts under conditions promoting bacterial growth. We therefore propose that campycins have the potential to lowerC. jejunicolonization levels in the chicken gut, the main reservoir and cause of human disease, representing a novel efficient antibacterial solution specifically developed to target this widespread foodborne pathogen.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3